AlphaYou
Overview
Smart money at a glance
Filings to Oct 13, 2026Net buying: insiders sold $0 and bought $20K on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- +$20K netNet buying
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 12- Open
- $11.11
- 52-wk high
- $13.11
- High
- $11.26
- 52-wk low
- $6.28
- Low
- $11.08
- Prev close
- $11.01
- Mkt cap
- $3.81B
- P/E
- 112.1x
- Volume
- 313.0K
- Fwd P/E
- 140.8x
- Beta
- 0.56
- P/S
- 4.3x
- P/B
- 7.8x
- Profit margin
- +3.8%
- Op margin
- +9.7%
- ROE
- +7.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about TLX filings
Are insiders buying or selling Telix Pharmaceuticals Limited (TLX) stock?
Net buying: insiders sold $0 and bought $20K of TLX stock on the open market in the 90 days to Oct 13, 2026, according to SEC Form 4 filings. The largest was Smith, Darren Charlton (Group Chief Financial Officer), who bought $20K. The latest filing was on Sep 14, 2026.
Which members of Congress have traded TLX recently?
None. No member of Congress disclosed a TLX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this TLX smart-money data?
This summary uses filings available on Oct 13, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
7 funds hold a position and insiders have been net buying.
What insiders are doing
Buys (2)
- SD
Smith Darren Charlton
$20K
bought
- BC
Behrenbruch Christian
$997K
bought
How top traders are positioned
No tracked top-trader positions in TLX right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No reported figure for the latest quarter.
Company release linked above, where available
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 19, 2026 | Unavailable | - | Unavailable | Unavailable |
| Mar 31, 2026 | Mar 31, 2026 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 19, 2026 | $0.04 / $0.08Alpha Vantage | -$0.04 miss | Unavailable | Unavailable |
| Sep 30, 2025 | Oct 14, 2025 | -$0.09 / -$0.14Alpha Vantage | +35.25% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 20, 2025 | $0.01 / $0.21Alpha Vantage | -95.33% miss | Unavailable | Unavailable |
| Mar 31, 2025 | Apr 22, 2025 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2024 | Feb 20, 2025 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2024 | Oct 17, 2024 | Unavailable | - | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
What the street expects next
Financials
Is the business strong?
Richly priced and running thin margins.
- Net margin
- 3.8%
- P/E
- 112.10
- Forward P/E
- 140.85
- Market cap
- $3.8B
Valuation
- P/S4.28
- P/B7.85
Quality
- Operating margin9.7%
- ROE7.4%
- ROA2.7%
Growth
- Beta0.56
Technicals
Price structure
This stock's price action is mixed.
Trend
Mixed
40 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace